ATE401346T1 - Asthma-empfindlichkeitsort - Google Patents
Asthma-empfindlichkeitsortInfo
- Publication number
- ATE401346T1 ATE401346T1 AT03767837T AT03767837T ATE401346T1 AT E401346 T1 ATE401346 T1 AT E401346T1 AT 03767837 T AT03767837 T AT 03767837T AT 03767837 T AT03767837 T AT 03767837T AT E401346 T1 ATE401346 T1 AT E401346T1
- Authority
- AT
- Austria
- Prior art keywords
- gpra
- asthma
- gene
- locus
- describes
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 3
- 230000035945 sensitivity Effects 0.000 title 1
- 101000577224 Homo sapiens Neuropeptide S receptor Proteins 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 102100025258 Neuropeptide S receptor Human genes 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003917 human chromosome Anatomy 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43584602P | 2002-12-20 | 2002-12-20 | |
| US43789503P | 2003-01-03 | 2003-01-03 | |
| US45876703P | 2003-03-26 | 2003-03-26 | |
| US48600003P | 2003-07-09 | 2003-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401346T1 true ATE401346T1 (de) | 2008-08-15 |
Family
ID=32686287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03767837T ATE401346T1 (de) | 2002-12-20 | 2003-12-19 | Asthma-empfindlichkeitsort |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080182236A1 (de) |
| EP (1) | EP1572739B1 (de) |
| AT (1) | ATE401346T1 (de) |
| AU (1) | AU2003292273A1 (de) |
| DE (1) | DE60322259D1 (de) |
| WO (1) | WO2004056866A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005045038A2 (en) * | 2003-10-23 | 2005-05-19 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002018412A1 (en) * | 2000-08-28 | 2002-03-07 | Human Genome Sciences, Inc. | 17 human secreted proteins |
| US20020151046A1 (en) * | 2000-06-16 | 2002-10-17 | Glucksmann Maria Alexandra | 52871, a novel human G protein coupled receptor and uses thereof |
| EP1254220A1 (de) * | 1999-09-08 | 2002-11-06 | Lexicon Genetics Incorporated | Menschliche g protein-gekoppelten 7 transmembran-rezeptor und diese kodierende polynukleotide |
| WO2001048015A2 (en) * | 1999-12-28 | 2001-07-05 | Pharmacia & Upjohn Company | G protein-coupled receptors |
| US20030157558A1 (en) * | 1999-12-28 | 2003-08-21 | Matsumoto Shun-Ichiro | Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same |
| JP2001245666A (ja) * | 2000-03-06 | 2001-09-11 | Kyowa Hakko Kogyo Co Ltd | 新規ポリペプチド |
| EP2275557A1 (de) * | 2000-04-12 | 2011-01-19 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
| EP1329508B1 (de) * | 2000-10-13 | 2010-09-08 | Takeda Pharmaceutical Company Limited | Neues g-protein-gekoppeltes rezeptorprotein und seine dna |
| AU2002239291A1 (en) * | 2000-11-22 | 2002-06-03 | Tularik, Inc. | G protein coupled receptors |
| WO2002063004A2 (en) * | 2001-02-07 | 2002-08-15 | Incyte Genomics, Inc. | G-protein coupled receptors |
| WO2003007187A1 (fr) * | 2001-07-12 | 2003-01-23 | Takeda Chemical Industries, Ltd. | Procede d'evaluation de ligand et utilisation de ce procede |
| CA2460468C (en) * | 2001-09-14 | 2012-12-18 | Takeda Chemical Industries, Ltd. | Novel polypeptide, dna thereof and use of the same |
| EP1365030A1 (de) * | 2002-05-21 | 2003-11-26 | MTM Laboratories AG | G Protein-gekoppelte Rezeptoren als Marker für colorectale Läsionen |
-
2003
- 2003-12-19 EP EP03767837A patent/EP1572739B1/de not_active Expired - Lifetime
- 2003-12-19 US US10/539,565 patent/US20080182236A1/en not_active Abandoned
- 2003-12-19 WO PCT/FI2003/000973 patent/WO2004056866A1/en not_active Ceased
- 2003-12-19 AU AU2003292273A patent/AU2003292273A1/en not_active Abandoned
- 2003-12-19 DE DE60322259T patent/DE60322259D1/de not_active Expired - Lifetime
- 2003-12-19 AT AT03767837T patent/ATE401346T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1572739A1 (de) | 2005-09-14 |
| AU2003292273A1 (en) | 2004-07-14 |
| WO2004056866A1 (en) | 2004-07-08 |
| US20080182236A1 (en) | 2008-07-31 |
| EP1572739B1 (de) | 2008-07-16 |
| WO2004056866A8 (en) | 2005-07-21 |
| DE60322259D1 (de) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE482722T1 (de) | Therapeutische verwendung von anti-cs1- antikörpern | |
| LU93274I2 (fr) | Elotuzumab | |
| WO2008105797A3 (en) | Polynucleotides encoding novel pcsk9 variants | |
| WO2003029421A3 (en) | Regulated breast cancer genes | |
| MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
| IS8432A (is) | Mótefni sem bindast viðtaka hvítfrumuboða-4 | |
| EA200901436A1 (ru) | Антигенсвязывающие белки, связывающие par-2 | |
| ATE407698T1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
| SG156625A1 (en) | Method for measuring resistance or sensitivity to docetaxel | |
| WO2001064877A3 (en) | Human schizophrenia gene | |
| DK1411962T3 (da) | Terapi for pancreacancer med monoklonalt stof | |
| WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
| WO2003105773A3 (en) | Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: | |
| WO2003063773A3 (en) | Differentially-regulated prostate cancer genes | |
| WO2007000320A3 (de) | Verfahren zur diagnose von rheumatischen erkrankungen | |
| WO2004066933A3 (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
| ATE401346T1 (de) | Asthma-empfindlichkeitsort | |
| WO2005017102A3 (en) | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins | |
| WO2003064628A3 (en) | Novel proteins and nucleic acids encoding same | |
| ATE412903T1 (de) | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten | |
| WO2007143578A3 (en) | Perforin-2 proteins | |
| WO2006108051A3 (en) | Compositions and methods relating to alzheimer's disease | |
| DK1644493T3 (da) | Regulering af en kinase, 'reguleret i COPD kinase' (RC-kinase) | |
| WO2006029838A3 (en) | Secreted polypeptide species involved in alzheimer’s disease | |
| WO2008014296A3 (en) | Composition and method for treatment of tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |